gdc

Multiple Myeloma

Elotuzumab, First-in-Class Monoclonal Antibody Immuno­­therapy, Improves Outcomes in Patients with Multiple Myeloma
ImmunotherapyMultiple MyelomaWeb Exclusives
“This therapy is an innovative approach, one that combines the precision of a targeted, immune-based therapy with traditional myeloma therapy. The results are very encouraging, giving renewed hope to patients who have relapsed,” says ASCO President-Elect Julie M. Vose, MD, MBA, Chief of the Division of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha.
It's Our Cancer
Multiple MyelomaPatient Stories
Brenda and her son, Steve, share their respective stories as Brenda deals with a multiple myeloma diagnosis.
Genetic Risk Factors for Multiple Myeloma
Genetics & CancerMultiple Myeloma
The risks for multiple myeloma, a rare and aggressive blood cancer, have long been linked to increasing age (older than 65), male sex, and African-American race. However, researchers are now looking into genetic risk factors to better understand and treat the disease.
African Americans Are at Higher Risk for Multiple Myeloma, a Rare Blood Cancer
Multiple Myeloma
Studies indicate that African Americans are twice as likely to be diagnosed with multiple myeloma compared with Caucasians or other ethnic groups.
My Multiple Myeloma Journey: Saved by Being at the Right Place at the Right Time
Multiple MyelomaPatient StoriesSurvivorship
Although routine screenings and regular preventive care are at the forefront of early cancer detection, sometimes just being in the right place at the right time can make all the difference. 
What's New in Multiple Myeloma Therapy?
FDA Approvals, News & UpdatesMultiple MyelomaNewsworthy
In the first 3 months of 2015, new developments in myeloma drugs could have important implications for the survival and quality of life of patients with multiple myeloma.
Page 10 of 10
Results 91 - 96 of 96

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country